Rankings
▼
Calendar
VTYX Q1 2021 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$25M
Net Income
-$38M
EPS (Diluted)
$-0.77
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$80,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$0
Cash & Equivalents
$0
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$25M
-$2M
-1402.5%
Net Income
-$38M
-$2M
-1644.4%
← FY 2021
All Quarters
Q2 2021 →